ANGO vs MDT
ANGO: A medical technology company specializing in image-guided, minimally invasive devices for cardiovascular disease, vascular access, and oncology treatments. MDT: Medtronic is a global healthcare technology leader dedicated to alleviating pain, restoring health, and extending life through innovative medical devices and digital solutions.
Side-by-side fundamentals
| Metric | ANGO | MDT | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $11.23 | $87.75 | |
| Market cap | $472M | $112.2B | |
| P/E as of 2026-10-08 | n/a | 23.54 | |
| PEG as of 2026-10-08, 3-year EPS CAGR to FY2026 | n/a | 2.41 | |
| Net margin FY2026, SEC XBRL | -11.5% | +13.2% | MDT higher |
| Gross margin FY2026, SEC XBRL | +54.6% | n/a | |
| Operating margin FY2026, SEC XBRL | -12.5% | +17.8% | MDT higher |
| ROE FY2026, SEC XBRL | -21.5% | +9.7% | MDT higher |
| ROA FY2026, SEC XBRL | -13.8% | +5.2% | MDT higher |
| Debt / equity as of 2026-09-03 | 0.03 | 0.57 | ANGO lower |
| Revenue growth (YoY) as of 2026-09-03 | +9.5% | +8.4% | ANGO higher |
| Revenue CAGR (3y) SEC XBRL | -1.9% | +5.2% | MDT higher |
| Dividend yield as of 2026-09-03 | n/a | +3.1% | |
| Dividend streak (yrs) SEC XBRL | 0 | 14 | MDT higher |
| Beta as of 2026-09-03 | 1.02 | 0.36 | |
| 1-year return as of 2026-10-08 close | +1.0% | -10.3% | ANGO higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.